Point of Care Tests
Point-of-care testing (PoCT) devices are characterised by their portability, ease of use and facilitation of quick and accurate testing at the point of initial contact with the patient.
These characteristics allow an increased access to modern medicine and enable earlier diagnosis and treatment of diseases, thus improving health care and reducing its overall costs.
MHS is a specialist Point-of-Care Testing company and NHS specialist supplier.
High quality medical testing products and years of experience make us an attractive and reliable partner for our many customers and agents.
Established physicians of all fields, as well as hospitals and pharmacies, rank among our satisfied and long-term clients.
Healthcare in the UK
Healthcare is constantly evolving.
As new technologies and point of care diagnostic processes are introduced into the NHS, patient outcomes improve, which result in better quality of healthcare.
MHS continues to be at the leading edge of these developments and continues to provide support to better patient outcomes in the UK and across the globe.
Point of care tests
Summary of advantages:
MHS medical rapid tests are based on the latest scientific break-throughs.
We know that a fast and clear diagnosis is crucial in minimizing the risk of infection and delivering timely therapy, which can prevent the progression of serious diseases.
Effective diagnostic medical tests are particularly important in the treatment of children, since they may often be unable to sufficiently describe their symptoms.
Insurance underwriters also benefit from rapid diagnostic tests that can quickly identify life threatening ailments and infections when assessing risks.
MHS Point of Care Tests provide:
- Highest Quality
- High sensitivity and specificity
- 99.9% accuracy
- On-site testing and diagnosis
- Easy to use
- Huge range
- Quick and reliable test results
- Cost efficient diagnosis
- Avoid the limitations of laboratory testing
- Competent and caring consultation
- All products are CE certified
- Up to 24 month shelf life
- Warranty for all tests
Here is a brief overview of some of our current point-of-care tests:
Cardiology Point of Care Tests
Every year, an estimated 17 million people worldwide die from a CVD.
Acute and chronic heart conditions are currently key factors in morbidity and mortality rates, and early recognition is crucial for the prognosis.
For example, there is already irreversible and lasting damage to the heart muscle only six hours after cardiac infarction occurs.
This illustrates the importance of an early and accurate cardiological diagnosis.
The most prevalent are acute myocardial infarction (AMI) CVDs sudden cardiac arrest (SCA),congestive heart failure (CHF) and atherosclerosis.
With timely treatment, fatalities can often be prevented.
Concentration of important biomarkers in human blood after a myocardial infarction.
Cardiac markers can be detected by diagnostic testing measures which covers the concentration of certain proteins, i.e., biomarkers that indicate the presence or severity of cardiovascular disease (CVD).
MHS offers a range of point of care diagnostic tests including C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure.
MHS Point-of-care tests
Cardiology
Our cardiology tests can quickly identify bio-markers that can quickly assist clinicians to diagnose heart conditions that would normally take prolonged laboratory processes.
Infectious Diseases Hepatitis C rapid test
Hep C info for carers
Hepatitis C point of care test
Is an immunochromatographic test that allows the qualitative detection of antibodies for hepatitis C in serum and plasma.
Hepatitis C (HCV), which is a major cause of chronic liver disease, can cause cirrhosis of the liver. This test is for in-vitro diagnostic purposes and professional use only.
HIV a major blood borne infection
Which is particularly affecting women HIV tests for women at risk. Our
HIV point of care rapid test
can quickly help identify the infection. Our wide range of
Oncology point of care rapid tests
can quickly identify bilogical markers for a wide range of cancers, including:
Bladder cancer POC test
Testicular cancer POC test
Prostate cancer POC test
Cancer Cancer support Early therapy and active precautions against cancer can, in many cases, save or prolong the life of the patient.
Therefore, all patients with risk factors for cancer should in our view schedule regular medical screening examinations.
Bowel Cancer POC Test
Approximately 48,000 cases of intestinal (bowel) cancer are diagnosed every year in the United Kingdom, and approximately 21,000 of those diagnosed will die as a result.
This number can be greatly reduced with preventive screening.
Immunological rapid test for detection of occult blood in feces is a useful diagnostic tool.
An overview of benefits: MHS FOB test include:
- High sensitivity : 2 μg/g
- Simple and easy reading
- Result in 5 minutes
- Storage at room temperature
- Long life: 18 months
- No cross reactivity with haemoglobin
MHS offers a wide range of point of care rapid medical tests and aredeveloping automated systems to speed up the process.
Automated POC Device readers
Following the inexorable trend towards decentralisation of medical services, MHS has pioneered PoCT technology that performs automated in-vitro diagnostic (IVD) testing of an arbitrary combination of biomarkers.
The new Mini Lab significantly increases throughput of point-of-care diagnostic test results relative to the user hands-on time and relative to manually operated IVD tests moving towards the effective throughput of large laboratory-based instruments.
Contact us for further information and our latest technology and a catalogue of point of care tests available or visit the NHS supply chain site.
Call centre 01274 591792
CE Certified
